Real-World Response to Dupilumab as Add-on Therapy in Adults and Adolescents with Type 2 Severe Asthma: A Spanish Cohort Study.

J Asthma Allergy · 2026 · PMC13055851 · PMID 41953432

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significancep =0.08so close (0.05 < p ≤ 0.1)

The proportion of patients achieving asthma control (ACT ≥20) at 12 months was numerically lower in the OCS-dependent group, but this did not reach statistical significance ( p =0.08).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.